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Several years ago, we synthesized a collection of $2500 small molecules and screened it for inhibition of membrane traffic from the endoplasmic reticulum (ER) to the plasma membrane via the Golgi apparatus [4] . We identified the structurally related compounds secramine A and secramine B as inhibitors of protein export from the Golgi apparatus to the plasma membrane and subsequently found that they inhibit association of the small Rho GTPase Cdc42 with membranes [5] . Rho GTPases cycle between an inactive, GDP-bound conformation, and an active, GTP-bound conformation. They are best known for regulating actin cytoskeleton dynamics [6] , but they also participate in membrane traffic, cell-cell contact, cell-cycle progression, and cell polarity [7] .
To investigate whether secramines also inhibit membrane traffic in the reverse direction, namely from the Golgi to the ER, we next studied the effect of secramine B on cholera toxininduced Cl À secretion. Cholera toxin is the major pathogenic factor causing disease in V. cholerae infection. The toxin is an enzyme that acts by entering the cytoplasm of host cells to activate adenylyl cyclase, which converts ATP to cAMP and thereby stimulates Cl À secretion. To access the cytoplasm, cholera toxin binds to receptors on the plasma membrane and traffics to the trans-Golgi network and then to ER [30] , where the enzymatically active portion, the A1 chain, unfolds and passes into the cytoplasm by co-opting the endogenous ER retro-translocation machinery [8] . 
Materials and Methods

Reagents
Secramine B was synthesized as previously described [5] and stored in 20 mM aliquots in DMSO at À20 8C. 
Electrophysiology assays
Cl À secretion, assessed as short circuit current (Isc), and transepithelial resistance were measured using standard electrophysiological techniques with T84 cell monolayers grown on 0.33 cm 2 inserts [10] . Vehicle represents the addition of 0.25% BSA and 0.2% DMSO to the basolateral media. Secramine B, pirl1 and pirl1.6 were only added to the basolateral media and concentrations are reported as the total volume around the cell monolayers (200 mL apical media + 1000 mL basolateral media). A higher percentage of DMSO (above 0.5%) reduces the transepithelial resistance and BSA serves as a carrier for secramine B (data not shown).
Where used, forskolin, carbachol, 8Br-cAMP, and barium chloride were added to the basolateral media and cholera toxin was added to the apical media. Data were fitted to a variable slope sigmoidal dose response curve and plotted using GraphPad Prism 3.0.
2.3.
Short-circuit current measurement in semipermeabilized monolayers were determined in cells permeabilized basolaterally using 100 mM amphotericin B, in the presence of symmetric high Cl À buffer (0.7 mM NaPO 4 , 0.43 mM KPO 4 , 1.25 mM CaCl 2 , 0.4 mM MgSO 4 , 142.3 mM choline, 10 mM HEPES, 5.6 mM Dglucose, pH 7.4) with transmembrane potential clamped at +10 mV (apical) [12] . For ðIsc-bl K Þ, transepithelial currentvoltage relationships (I-V curves) were defined by measuring transepithelial currents during 1 s voltage clamp periods ranging from À80 to +80 mV and normalized to baseline Isc at rest as described [12] . Baseline I-V curves obtained in the absence of agonist were subtracted from those measured after agonist treatment to calculate agonist-induced currents. 1B) and had no effect on transepithelial resistance (TER) over a 5 h incubation period, indicating that intercellular tight junctions were not affected and the monolayers remained intact (TER = 1080 and 1180 V cm 2 with 25 mM secramine B and vehicle, respectively, at 5 h).
Results
Secramine B inhibits cAMP-induced Cl
To distinguish whether secramine B inhibited the retrograde traffic of cholera toxin from the Golgi to the ER, or the signaling pathway leading to Cl À secretion, we applied forskolin, a direct activator of adenylyl cyclase, to increase the intracellular levels of cAMP or 8Br-cAMP, a membranepermeable analog of cAMP. Secramine B inhibited Cl À secretion by >90% in the presence of 10 mM forskolin ( Fig. 2A ) or 3 mM 8Br-cAMP (Fig. 2B ). Secramine B acted with an IC 50 of $3.4 mM (Fig. 2C) . When added after the forskolin-induced Isc was maximal, secramine B still potently inhibited Cl À secretion with a half-time of approximately 17 min (Fig. 2D) . Thus, the entire inhibitory effect of secramine B on the cholera toxin-induced increase in Cl À secretion can be explained by inhibition of a step(s) downstream of retrograde traffic from Golgi to ER and cAMP production. Both the NKCC transporter and the Na + , K + ATPase are required for cAMP-and Ca 2+ -elicited Cl À secretion [14, 15] .
Therefore, we tested whether secramine might also inhibit Cl À secretion caused by the muscarinic agonist carbachol that acts by inducing an increase in intracellular Ca 2+ . Secramine B had no detectable effect on the Isc induced by carbachol (Fig. 3) . Based on these observations, we reasoned that secramine B inhibited either the apical CFTR or the cAMP-gated basolateral K + channel.
To test whether secramine B inhibited the CFTR channel, we monitored Cl À flux across the apical membranes of T84 monolayers in response to forskolin in the presence of amphotericin B, a polyene that forms channels for monovalent ions and small molecules. Under these conditions, the forskolin-induced transepithelial Isc is only due to Cl À transport across the apical membrane. Confluent monolayers of T84 cells were placed in symmetrical solutions containing only Cl À as the major charge carrying permeant ion. We then selectively permeabilized the basolateral membranes with amphotericin B, and clamped the apical membrane potential at 10 mV [11] . Under these conditions, secramine B had no effect on the Cl to the apical membrane of T84 cells. We immersed confluent monolayers of T84 cells in asymmetrical solutions containing K + as the major charge carrying permeant ion, permeabilized the apical membranes with amphotericin B, and clamped the transepithelial voltage at 0 mV [11] . The apical solution had a seven-fold higher concentration of K + . Forskolin (10 mM)
induced a strong K + current across the basolateral membrane ðIsc-bl K Þ that was inhibited by 20 mM secramine B (Fig. 4B ). Subsequent addition of 3 mM BaCl 2 rapidly and strongly inhibited the cAMP-gated K + channel activity [16] . Barium does not inhibit carbachol-stimulated K + channel activity [17] . Upon addition of carbachol, we observed transient and strong basolateral K + efflux in both secramine-treated and untreated monolayers, indicating that secramine B-treated monolayers were still intact and transport-competent and that secramine B had no effect on Ca 2+ -gated K + channel activity. Steady-state Isc-bl K =V relationships after stimulation of T84 monolayers with forskolin also demonstrated that secramine B inhibited cAMP-induced K + conductance as evidenced by the lower slope of the current-voltage isotherm (Fig. 4C) . These results show that secramine B selectively attenuated K + efflux through a cAMP-regulated and Ba 2+ -sensitive basolateral K + efflux pathway, presumably via the
Rho GTPase activity and cAMP-dependent Cl
S secretion
We have shown that secramine B inhibits the Rho GTPase Cdc42 in vitro, and proposed that secramine B also targets Cdc42 in cells because it phenocopies perturbations in membrane traffic resulting from expression of Cdc42 mutants [5] . Pirl1 is a small molecule structurally unrelated to secramine B (Fig. 5A ) that also inhibits Cdc42 in vitro in a manner similar to secramine B [9] . Incubation of T84 cells with pirl1, but not its inactive analog pirl1.6 (Fig. 5B, [9] ), inhibited forskolin-induced Cl À flux (Fig. 5B-D 
Discussion
Here we provide evidence that secramine B and pirl1, two structurally distinct small molecules that inhibit activation and signaling by the Rho GTPase Cdc42, prevented cAMPinduced, but not Ca 2+ -induced, Cl À transport in polarized T84 epithelial cells. Secramine B acted by inhibiting a basolateral cAMP-dependent K + channel, likely comprised of the voltagegated KCNQ1 and its modulatory KCNE3 subunits [2] . This channel, but not the related KCNE1, is expressed in the T84 cells and opens in response to cAMP agonists [2] . Neither the Ca 2+ -gated K + channel KCNN4 nor the Cl À channel CFTR were affected by secramine B. These results provide pharmacological evidence that Rho GTPases regulate cAMP-dependent Cl À secretion and basolateral K + efflux. Precisely how Rho
GTPases regulate these processes remains to be determined. Rho GTPases likely regulate Cl À secretion downstream of cAMP production either through alterations in the organization of the basolateral actin cytoskeleton or transport of channels, channel components, or channel regulators to the basolateral membrane. Elevation of cAMP causes a loss of basement stress fibers and an increase in actin bundles along the lateral membranes of T84 cells [18] . Prevention of this actin redistribution by stabilizing the actin stress fibers with NBDphallicidin inhibits cAMP-induced Cl À secretion in T84 cells [18] . Both secramine B and pirl1 prevent Cdc42-dependent actin polymerization in cell extracts and pirl1 inhibits PMAinduced actin rearrangements in monkey kidney epithelial BS-C-1 cells [5, 9] . Like secramine B and pirl1, NBD-phallicidin does not interfere with Ca 2+ -mediated Cl À secretion induced by carbachol [18] . Among the Rho GTPases, RhoA activation stimulates stress fiber formation and Cdc42 and Rac1 activation stimulate actin-based structures along the cell periphery [6] . Therefore, the cytoskeletal rearrangements downstream of cAMP production are consistent with an inhibition of RhoA and a stimulation of Rac1 and Cdc42. In accordance with these expected changes, PKA, activated upon increases in cAMP, directly phosphorylates RhoA to inhibit its function [19, 20] and indirectly activates Cdc42 [21] , possibly through phosphorylation of guanine nucleotide exchange factor for Cdc42 [22] . Importantly, although both the secramines and pirl1 inhibit Cdc42 activation, neither inhibits activation of RhoA as monitored by stress fiber stability [5, 9] . Thus, the activities of secramine B and pirl1 are consistent with an inhibition of the normal cytoskeletal changes that accompany elevations in cAMP and suggest that cAMP-induced K + channel activity may depend on these cytoskeletal changes. Alternatively, cAMP-activated K + channel activity may require Cdc42-dependent membrane traffic. In polarized epithelial cells, overexpression of dominant inhibitory mutants of Cdc42 disrupts membrane traffic of newly synthesized proteins to the basolateral membrane [23] [24] [25] and recycling of basolateral proteins to the basolateral membrane after endocytosis [23] . Therefore, by interfering with Cdc42 activity, secramine B and pirl1 may inhibit the mobilization of membrane-bound components of a fully functional cAMP-activated basolateral K + channel.
These studies do not rule out the possibility that secramine B and pirl1 inhibit cAMP-gated K + channel activity independent of an effect on Rho GTPases. Secramine B might bind directly to and inhibit the cAMP-gated K + conductance. Such a mechanism of inhibition by direct binding to this channel was shown for chromanol 293B, a small molecule that, like secramine B, also does not inhibit Ca 2+ -induced Cl À flux [26, 27] . Furthermore, the KCNQ1 subunit is a promiscuous drug target, having been shown to bind to different small molecules [28] . This possibility, however, seems unlikely since pirl1.6, a small molecule that is highly similar to pirl1 but nevertheless does not inhibit Cdc42 activation, failed to inhibit forskolin-stimulated Cl À transport.
Blockade of the cAMP-gated K + conductance by secramine B resulted in strong inhibition of the intestinal Cl À secretory response. In addition to identifying a new reagent to dissect critically important K + channels [29] , this study pharmacologically links Rho GTPases to Cl À secretion and thus provides a new avenue to dissect and elucidate the pathway of cAMPelicited Cl À secretion in intestinal crypt epithelial cells.
